Form 4 for CHRN ChronoScale Holdings Corp
Accepted 2022-12-07 00:00:00 ET · period of report 2022-12-04 · accession 0001549084-22-000078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-07 | 2022-12-04 | CHRN | SHERMAN STEVEN | Executive COB, Dir | M - OptEx | $0.00 | +31.2K | 739.2K | +4% | $0 |
| D | 2022-12-07 | 2022-12-04 | CHRN | SHERMAN STEVEN | Executive COB, Dir | A - Grant | $0.00 | +242.7K | 971.3K | +33% | $0 |
| D | 2022-12-07 | 2022-12-04 | CHRN | SHERMAN STEVEN | Executive COB, Dir | S - Sale+OE | $1.28 | -10.6K | 728.7K | -1% | -$13.5K |
| D | 2022-12-07 | 2022-12-04 | CHRN | SHERMAN STEVEN | Executive COB, Dir | M - OptEx | $0.00 | -31.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-04 | M | A | 31,198 | $0.00 | 739,240 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-04 | A | A | 242,679 | $0.00 | 971,343 | D | — | — | (F3) The grant of restricted stock units ("RSUs") was approved by the Issuer's Board of Directors on December 4, 2022 in accordance with the terms of the Issuer's Amended and Restated 2014 Equity Incentive Plan. Each RSU represents the economic equivalent of one share of the Issuer's common stock and shall be settled in shares of the Issuer's common stock upon vesting. The RSUs shall fully vest on January 31, 2023. (F4) Includes 242,579 unvested RSUs. |
| 3 | Common | Common Stock | 2022-12-04 | S | D | 10,576 | $1.28 | 728,664 | D | — | — | (F1) Represents shares sold by the Reporting Person on December 7, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the remaining securities under a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022. (F2) The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $1.2700 to $1.3310, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request. |
| 4 | Derivative | Restricted Stock Units | 2022-12-04 | M | D | 31,198 | $0.00 | 0 | D | — · — to — | 31,198 Common Stock | (F5) The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date"). (F6) On December 4, 2022, the Issuer's Board of Directors approved an amendment to the vesting schedule of the RSUs such that the RSUs fully vested and were delivered to the Reporting Person upon settlement. |